Ruth Harvey

5.1k total citations
34 papers, 688 citations indexed

About

Ruth Harvey is a scholar working on Epidemiology, Infectious Diseases and Animal Science and Zoology. According to data from OpenAlex, Ruth Harvey has authored 34 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 13 papers in Infectious Diseases and 9 papers in Animal Science and Zoology. Recurrent topics in Ruth Harvey's work include Influenza Virus Research Studies (21 papers), Respiratory viral infections research (13 papers) and Animal Virus Infections Studies (9 papers). Ruth Harvey is often cited by papers focused on Influenza Virus Research Studies (21 papers), Respiratory viral infections research (13 papers) and Animal Virus Infections Studies (9 papers). Ruth Harvey collaborates with scholars based in United Kingdom, United States and Japan. Ruth Harvey's co-authors include William Barclay, Othmar G. Engelhardt, James S. Robertson, Dean Clarke, David J. Rowlands, Stephen Griffin, Mark Harris, Kate Guilfoyle, Andrew C.R. Martin and Maria Zambon and has published in prestigious journals such as Nature Communications, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Ruth Harvey

31 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth Harvey United Kingdom 16 388 255 172 98 91 34 688
Bernadette Crescenzo-Chaigne France 12 314 0.8× 257 1.0× 142 0.8× 114 1.2× 25 0.3× 19 562
Victor H. Leyva-Grado United States 16 636 1.6× 292 1.1× 172 1.0× 302 3.1× 20 0.2× 22 935
Harvey Holmes United Kingdom 14 279 0.7× 443 1.7× 102 0.6× 113 1.2× 50 0.5× 28 738
Xinliang Shen China 9 209 0.5× 356 1.4× 275 1.6× 89 0.9× 89 1.0× 22 800
Tomokazu Tamura Japan 14 99 0.3× 311 1.2× 160 0.9× 79 0.8× 54 0.6× 44 712
Tijana Ivanovic United States 15 256 0.7× 350 1.4× 274 1.6× 84 0.9× 42 0.5× 18 746
Stephen M. Laidlaw United Kingdom 16 366 0.9× 151 0.6× 279 1.6× 246 2.5× 54 0.6× 28 981
Vladimir Y. Lugovtsev United States 13 407 1.0× 127 0.5× 138 0.8× 100 1.0× 10 0.1× 20 494
Shigeyuki Itamura Japan 18 857 2.2× 640 2.5× 215 1.3× 480 4.9× 27 0.3× 45 1.4k
Lisa A. Lopez United States 9 240 0.6× 331 1.3× 150 0.9× 140 1.4× 15 0.2× 11 671

Countries citing papers authored by Ruth Harvey

Since Specialization
Citations

This map shows the geographic impact of Ruth Harvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Harvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Harvey more than expected).

Fields of papers citing papers by Ruth Harvey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Harvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Harvey. The network helps show where Ruth Harvey may publish in the future.

Co-authorship network of co-authors of Ruth Harvey

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Harvey. A scholar is included among the top collaborators of Ruth Harvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Harvey. Ruth Harvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huddleston, John, Andrea N. Loes, S. Richard Turner, et al.. (2025). Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025. Virus Evolution. 11(1). veaf086–veaf086. 1 indexed citations
2.
Faustini, Sian, Claire Backhouse, Niharika A. Duggal, et al.. (2025). Time of day of vaccination does not influence antibody responses to pneumococcal and annual influenza vaccination in a cohort of healthy older adults. Vaccine. 49. 126770–126770. 1 indexed citations
3.
Stevenson-Leggett, Phoebe, Lorin Adams, David Greenwood, et al.. (2025). Investigation of Influenza A(H5N1) Virus Neutralization by Quadrivalent Seasonal Vaccines, United Kingdom, 2021–2024. Emerging infectious diseases. 31(6). 1202–1206. 2 indexed citations
4.
Proust, Alizé, Christophe J. Queval, Ruth Harvey, et al.. (2023). Differential effects of SARS-CoV-2 variants on central nervous system cells and blood–brain barrier functions. Journal of Neuroinflammation. 20(1). 184–184. 34 indexed citations
5.
Calder, Lesley J., et al.. (2022). Electron cryotomography of SARS-CoV-2 virions reveals cylinder-shaped particles with a double layer RNP assembly. Communications Biology. 5(1). 1210–1210. 13 indexed citations
6.
Hall, Ross S., Anabel Guedán, Melvyn W. Yap, et al.. (2022). SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export. PLoS Pathogens. 18(8). e1010349–e1010349. 31 indexed citations
7.
Daniels, Rodney S., Ruth Harvey, Burcu Ermetal, et al.. (2021). A Sanger sequencing protocol for SARS‐CoV‐2 S‐gene. Influenza and Other Respiratory Viruses. 15(6). 707–710. 14 indexed citations
8.
Maguire, Paula, Sinéad T. Loughran, Ruth Harvey, & Patricia Johnson. (2021). A TLR5 mono-agonist restores inhibited immune responses to Streptococcus pneumoniae during influenza virus infection in human monocytes. PLoS ONE. 16(10). e0258261–e0258261. 3 indexed citations
9.
Wrobel, Antoni G., D.J. Benton, Saira Hussain, et al.. (2020). Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein. Nature Communications. 11(1). 5337–5337. 28 indexed citations
10.
New, Roger, Rachel Mahood, Mark S. Lever, et al.. (2019). Antibody-mediated protection against MERS-CoV in the murine model. Vaccine. 37(30). 4094–4102. 7 indexed citations
11.
Brown, Jonathan C., William Barclay, Mónica Galiano, & Ruth Harvey. (2019). Passage of influenza A/H3N2 viruses in human airway cells removes artefactual variants associated with neuraminidase-mediated binding. Journal of General Virology. 101(5). 456–466. 8 indexed citations
12.
Loughran, Sinéad T., Paula Maguire, Paul Buchanan, et al.. (2018). Influenza infection directly alters innate IL-23 and IL-12p70 and subsequent IL-17A and IFN-γ responses to pneumococcus in vitro in human monocytes. PLoS ONE. 13(9). e0203521–e0203521. 15 indexed citations
13.
Nicolson, Carolyn, Ruth Harvey, Othmar G. Engelhardt, & James S. Robertson. (2016). The Ability of a Non-Egg Adapted (Cell-Like) A(H1N1)pdm09 Virus to Egg-Adapt at HA Loci Other than 222 and 223 and Its Effect on the Yield of Viral Protein. PLoS ONE. 11(11). e0166761–e0166761. 4 indexed citations
14.
Mattiuzzo, Giada, Carolyn Nicolson, Dianna E. Wilkinson, et al.. (2015). Development of Lentivirus-Based Reference Materials for Ebola Virus Nucleic Acid Amplification Technology-Based Assays. PLoS ONE. 10(11). e0142751–e0142751. 15 indexed citations
15.
Harvey, Ruth, James S. Robertson, Philip D. Minor, et al.. (2012). Application of deglycosylation to SDS PAGE analysis improves calibration of influenza antigen standards. Biologicals. 40(1). 96–99. 18 indexed citations
16.
17.
Nicolson, Carolyn, Ruth Harvey, Rachel Johnson, et al.. (2011). An additional oligosaccharide moiety in the HA of a pandemic influenza H1N1 candidate vaccine virus confers increased antigen yield in eggs. Vaccine. 30(4). 745–751. 18 indexed citations
18.
Harvey, Ruth, Carolyn Nicolson, Rachel Johnson, et al.. (2010). Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin molecules. Vaccine. 28(50). 8008–8014. 28 indexed citations
19.
Harvey, Ruth, et al.. (2008). Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1). Vaccine. 26(51). 6550–6554. 49 indexed citations
20.
Harvey, Ruth. (2004). Two partimens involving Peirol: BdT 366, 10=119'2and BdT 366,30. 64(1). 187–205. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernadette Crescenzo-Chaigne Breakdown of academic impact, for papers by Victor H. Leyva-Grado Breakdown of academic impact, for papers by Harvey Holmes Breakdown of academic impact, for papers by Xinliang Shen Breakdown of academic impact, for papers by Tomokazu Tamura Breakdown of academic impact, for papers by Tijana Ivanovic Breakdown of academic impact, for papers by Stephen M. Laidlaw Breakdown of academic impact, for papers by Vladimir Y. Lugovtsev Breakdown of academic impact, for papers by Shigeyuki Itamura Breakdown of academic impact, for papers by Lisa A. Lopez
Rankless by CCL
2026